| 6001 | Biological Father: High cholesterol | GCST90475242 | 0.80 |
| 6002 | TNFRSF8/TNFRSF9 ratio | GCST90315940 | 0.80 |
| 6003 | rfMRI connectivity (ICA100 edge 399) | GCST90005252 | 0.80 |
| 6004 | TBL1X levels | GCST90470815 | 0.80 |
| 6005 | Eicosenoylcarnitine (C20:1) levels | GCST90200148 | 0.80 |
| 6006 | IL7 levels | GCST90469606 | 0.80 |
| 6007 | Non-mucinous epithelial ovarian cancer | GCST90244167 | 0.80 |
| 6008 | IDP dMRI TBSS OD Cerebral peduncle L | GCST90004417 | 0.80 |
| 6009 | CLPP levels | GCST90468785 | 0.80 |
| 6010 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T200 | ECGA000200 | 0.80 |
| 6011 | CD14 levels | GCST90468598 | 0.80 |
| 6012 | Lysoalkenylphosphatidylethanolamine (P-20:0) levels | GCST90025460 | 0.80 |
| 6013 | Cerebral amyloid angiopathy | FING00000262 | 0.80 |
| 6014 | CFHR4 levels | GCST90468727 | 0.80 |
| 6015 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T291 | ECGA000291 | 0.80 |
| 6016 | SHBG levels | UKBB00000767 | 0.80 |
| 6017 | CD40LG levels | GCST90468632 | 0.80 |
| 6018 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T321 | ECGA000321 | 0.80 |
| 6019 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 67) | GCST90320886 | 0.80 |
| 6020 | Physical decline (log-difference score) | GCST90565847 | 0.80 |
| 6021 | Unspecified/other endometriosis | FING00001404 | 0.79 |
| 6022 | MMP1/MMP3 ratio | GCST90315461 | 0.79 |
| 6023 | Do you currently smoke cigarettes? | GCST90476388 | 0.79 |
| 6024 | Normotensive glaucoma | FING00000892 | 0.79 |
| 6025 | IDP dMRI TBSS MD Pontine crossing tract | GCST90004028 | 0.79 |
| 6026 | CLMP/TGFBR2 ratio | GCST90314135 | 0.79 |
| 6027 | EREG/ITGB1BP2 ratio | GCST90314703 | 0.79 |
| 6028 | Recent worrying too much about different things | Anxiety | UKBB00000746 | 0.79 |
| 6029 | Triacylglycerol_53:2_[M+NH4]1+ levels | GCST90060531 | 0.79 |
| 6030 | Primary gonarthrosis, bilateral | FING00001213 | 0.79 |
| 6031 | DTI TBSS MO Medial lemniscus R | GCST90384628 | 0.79 |
| 6032 | CTSO levels | GCST90468915 | 0.79 |
| 6033 | Mean carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasound | UKBB00000445 | 0.79 |
| 6034 | Arm fat-free mass (right) | Impedance measures | UKBB00000048 | 0.79 |
| 6035 | Other obstetric trauma | FING00001082 | 0.79 |
| 6036 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T276 | ECGU000276 | 0.79 |
| 6037 | CPVL levels | GCST90468848 | 0.79 |
| 6038 | Trunk predicted mass | Impedance measures | UKBB00000866 | 0.79 |
| 6039 | ANGPTL1 levels | GCST90468302 | 0.79 |
| 6040 | Other disorders of patella | FING00001032 | 0.79 |
| 6041 | Current Smoker | FING00000371 | 0.79 |
| 6042 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T450 | ECGU000450 | 0.79 |
| 6043 | TNFRSF10C levels | GCST90470901 | 0.79 |
| 6044 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T332 | ECGU000332 | 0.79 |
| 6045 | Multi-site chronic pain | Other trait | UKBB00000490 | 0.78 |
| 6046 | Leg predicted mass (right) | Impedance measures | UKBB00000397 | 0.78 |
| 6047 | CD300C/NBL1 ratio | GCST90313792 | 0.78 |
| 6048 | Left-hemisphere visual network to left-hemisphere somatomotor network white-matter structural connectivity | GCST90302649 | 0.78 |
| 6049 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T305 | ECGU000305 | 0.78 |
| 6050 | SFTPA2/SFTPD ratio | GCST90315839 | 0.78 |
| 6051 | BAP18 levels | GCST90468422 | 0.78 |
| 6052 | IDP dMRI TBSS L2 Superior longitudinal fasciculus L | GCST90004164 | 0.78 |
| 6053 | Average log acceleration during the five least active hours of the day | GCST90061431 | 0.78 |
| 6054 | Bone marrow fat fraction of thoracic vertebra 12 | GCST90652384 | 0.78 |
| 6055 | ARL13B levels | GCST90468363 | 0.78 |
| 6056 | IDP dMRI TBSS MD Retrolenticular part of internal capsule L | GCST90004048 | 0.78 |
| 6057 | Seen a psychiatrist for nerves, anxiety, tension or depression | Mental health | UKBB00000764 | 0.78 |
| 6058 | FSTL3 levels | GCST90469272 | 0.78 |
| 6059 | SEMA3G levels | GCST90470571 | 0.78 |
| 6060 | ALB levels | GCST90497108 | 0.78 |
| 6061 | CD83/HAVCR2 ratio | GCST90313904 | 0.78 |
| 6062 | DTI TBSS L2 Retrolenticular part of internal capsule R | GCST90384496 | 0.78 |
| 6063 | CFB levels | GCST90240778 | 0.78 |
| 6064 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 8) | GCST90320827 | 0.78 |
| 6065 | Forced expiratory volume in 1-second (FEV1), predicted | Spirometry | UKBB00000252 | 0.77 |
| 6066 | MBL2 levels | GCST90469868 | 0.77 |
| 6067 | ICD10 D25: Leiomyoma of uterus | GCST90454204 | 0.77 |
| 6068 | F-cooking flavour liking (derived food-liking factor) | GCST90094742 | 0.77 |
| 6069 | Whole body fat-free mass | Impedance measures | UKBB00000915 | 0.77 |
| 6070 | Diseases of liver | FING00000425 | 0.77 |
| 6071 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T199 | ECGA000199 | 0.77 |
| 6072 | Hair colour (natural, before greying): Dark brown (UKB data field 1747_4) | GCST90041839 | 0.77 |
| 6073 | Triacylglycerol_51:2_[M+NH4]1+ levels | GCST90060497 | 0.77 |
| 6074 | BACH1/EIF4G1 ratio | GCST90313438 | 0.77 |
| 6075 | CDH2 levels | GCST90468673 | 0.77 |
| 6076 | TYMP levels | GCST90470996 | 0.77 |
| 6077 | Total Dihexosylceramide levels | GCST90025821 | 0.77 |
| 6078 | CD79B/FCRL2 ratio | GCST90313900 | 0.77 |
| 6079 | Cholelithiasis | FING00000275 | 0.77 |
| 6080 | HJV levels | GCST90469455 | 0.77 |
| 6081 | Weight | Body size measures | UKBB00000909 | 0.77 |
| 6082 | Acceptance of an invitation to wear a physical activity monitor | GCST90012791 | 0.77 |
| 6083 | CCL11/CCL13 ratio | GCST90313671 | 0.77 |
| 6084 | CLEC1B/GP1BA ratio | GCST90314091 | 0.77 |
| 6085 | IDP dMRI TBSS L2 Posterior corona radiata R | GCST90004149 | 0.77 |
| 6086 | SFRP1 levels | GCST90470610 | 0.76 |
| 6087 | IL1RN levels | GCST90012004 | 0.76 |
| 6088 | CRHBP levels | GCST90468860 | 0.76 |
| 6089 | Cucumber liking | GCST90094749 | 0.76 |
| 6090 | Right-hemisphere control network to right-hemisphere default mode network white-matter structural connectivity | GCST90302835 | 0.76 |
| 6091 | Docosahexaenoic acid to total fatty acids percentage | GCST90502284 | 0.76 |
| 6092 | DTI TBSS MD Posterior thalamic radiation R | GCST90384600 | 0.76 |
| 6093 | Prescriptions - doxazosin | alpha1-antagonist,alpha blocker | UKBB00000679 | 0.76 |
| 6094 | FAM3C levels | GCST90469187 | 0.76 |
| 6095 | Monounsaturated fatty acid levels | GCST90502363 | 0.76 |
| 6096 | IGLL1 levels | GCST90241473 | 0.76 |
| 6097 | Shoulder lesions | Other soft tissue disorders | UKBB00000769 | 0.76 |
| 6098 | CD59 levels | GCST90468639 | 0.76 |
| 6099 | Usual walking pace | Physical activity | UKBB00000891 | 0.76 |
| 6100 | GRAP2/MAP4K5 ratio | GCST90314982 | 0.76 |
| 6101 | MOCS2 levels | GCST90469928 | 0.75 |
| 6102 | PPP1R2/USP8 ratio | GCST90315723 | 0.75 |
| 6103 | Fat-free mass | GCST007063 | 0.75 |
| 6104 | MYO9B levels | GCST90469982 | 0.75 |
| 6105 | DKK3/LTBP2 ratio | GCST90314487 | 0.75 |
| 6106 | Lymphoid neoplasms | GCST90624743 | 0.75 |
| 6107 | Left-hemisphere somatomotor network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302676 | 0.75 |
| 6108 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T90 | ECGA000090 | 0.75 |
| 6109 | Right-hemisphere somatomotor network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302788 | 0.75 |
| 6110 | CNTN5 levels | GCST90468807 | 0.75 |
| 6111 | ZNRF4 levels | GCST90471104 | 0.75 |
| 6112 | aparc-DKTatlas rh area caudalmiddlefrontal | GCST90003267 | 0.75 |
| 6113 | FOXO1/NFATC1 ratio | GCST90314873 | 0.75 |
| 6114 | MARCO/SIGLEC1 ratio | GCST90315387 | 0.75 |
| 6115 | Arm fat percentage right (UKB data field 23119) | GCST90468158 | 0.75 |
| 6116 | Cryptic phenotype that captures autosomal dominant polycystic kidney disease severity | GCST90101829 | 0.74 |
| 6117 | Cholelithiasis | GCST90468118 | 0.74 |
| 6118 | ENTPD5 levels | GCST90469121 | 0.74 |
| 6119 | Other haemoglobinopathies | FING00001053 | 0.74 |
| 6120 | CPXM1/MDK ratio | GCST90314221 | 0.74 |
| 6121 | IL17RB levels | GCST90469563 | 0.74 |
| 6122 | Beef/steak liking | GCST90094700 | 0.74 |
| 6123 | Acceptance of an invitation to participate in a mental health questionnaire | GCST90012792 | 0.74 |
| 6124 | Other diseases of upper respiratory tract | FING00001012 | 0.74 |
| 6125 | IDP dMRI TBSS OD Genu of corpus callosum | GCST90004404 | 0.74 |
| 6126 | MESD levels | GCST90469891 | 0.73 |
| 6127 | CDNF levels | GCST90468686 | 0.73 |
| 6128 | total creatine kinase (maximum, inv-norm transformed) | GCST90476410 | 0.73 |
| 6129 | MANSC1 levels | GCST90469847 | 0.73 |
| 6130 | Abnormal results of function study of liver (PheCode 573.7) | GCST90476097 | 0.73 |
| 6131 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T92 | ECGA000092 | 0.73 |
| 6132 | CALCOCO1/CASP3 ratio | GCST90313596 | 0.73 |
| 6133 | Phospholipids to Total Lipids in Large LDL percentage | GCST90498071 | 0.73 |
| 6134 | aparc-DKTatlas lh thickness lateraloccipital | GCST90003549 | 0.73 |
| 6135 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T224 | ECGU000224 | 0.73 |
| 6136 | PNLIP levels | GCST90470275 | 0.73 |
| 6137 | NCS1 levels | GCST90470011 | 0.73 |
| 6138 | Other circulatory problem | GCST90475217 | 0.73 |
| 6139 | Lysophosphatidylcholine (26:0) [sn2] levels | GCST90025428 | 0.73 |
| 6140 | Transient global amnesia | FING00001374 | 0.73 |
| 6141 | Leisure screen time | GCST90104339 | 0.73 |
| 6142 | CCL22/PDGFB ratio | GCST90313692 | 0.73 |
| 6143 | Gastro-oesophageal reflux disease | FING00000564 | 0.73 |
| 6144 | Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80) | GCST90668524 | 0.73 |
| 6145 | CDH17/PECAM1 ratio | GCST90313942 | 0.73 |
| 6146 | ADAMTS13 levels | GCST90468222 | 0.73 |
| 6147 | PRSS22 levels | GCST90470341 | 0.73 |
| 6148 | Docosahexaenoic acid to total fatty acids percentage | GCST90502285 | 0.73 |
| 6149 | Whole body water mass | Impedance measures | UKBB00000916 | 0.72 |
| 6150 | FABP1/RBP2 ratio | GCST90314753 | 0.72 |
| 6151 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T147 | ECGU000147 | 0.72 |
| 6152 | Liver iron content | GCST90016674 | 0.72 |
| 6153 | Septal defects | FING00001293 | 0.72 |
| 6154 | PRKAR2A levels | GCST90470327 | 0.72 |
| 6155 | Main speciality of consultant (recoded) - Cardiology | Summary Administration | UKBB00000414 | 0.72 |
| 6156 | CTRC/KIRREL2 ratio | GCST90314309 | 0.72 |
| 6157 | QPCT levels | GCST90470401 | 0.72 |
| 6158 | Inguinal hernia, bilateral | FING00000682 | 0.72 |
| 6159 | Phenylalanine levels | GCST90499223 | 0.72 |
| 6160 | Treatment/medication code - ibuprofen | Medications | UKBB00000847 | 0.72 |
| 6161 | HYOU1/RARRES2 ratio | GCST90315103 | 0.72 |
| 6162 | Triacylglycerol (54:1) [NL-18:1] levels | GCST90024563 | 0.72 |
| 6163 | IDP T1 FAST ROIs L hippocampus | GCST90002555 | 0.72 |
| 6164 | Sphingomyelin (d18:0/16:0) levels | GCST90025741 | 0.72 |
| 6165 | Urine andro steroid monosulfate C19H28O6S (1)* levels in chronic kidney disease | GCST90264796 | 0.72 |
| 6166 | POLR2F levels | GCST90470283 | 0.72 |
| 6167 | A1BG levels | GCST90468185 | 0.72 |
| 6168 | EPHA1 levels | GCST90469129 | 0.72 |
| 6169 | Impedance of arm right (UKB data field 23109) | GCST90468172 | 0.72 |
| 6170 | Histidine levels | GCST90497481 | 0.72 |
| 6171 | Cholesteryl Esters to Total Lipids in Large LDL percentage | GCST90497967 | 0.71 |
| 6172 | Mean corpuscular volume (UKB data field 30040) | GCST90468086 | 0.71 |
| 6173 | Alanine aminotransferase | Blood biochemistry | UKBB00000018 | 0.71 |
| 6174 | CX3CL1 levels | GCST90468921 | 0.71 |
| 6175 | Ceramide (d18:2/24:0) levels | GCST90024055 | 0.71 |
| 6176 | Platelet distribution width | GCST90002401 | 0.71 |
| 6177 | Platelet count at delivery | GCST90302227 | 0.71 |
| 6178 | Rheumatoid arthritis and other inflammatory polyarthropathies | musculoskeletal | UKBB00000758 | 0.71 |
| 6179 | Nontoxic goitre/thyroid nodule | FING00000887 | 0.71 |
| 6180 | AMBP/HYOU1 ratio | GCST90313255 | 0.71 |
| 6181 | CDH17/DSG2 ratio | GCST90313939 | 0.71 |
| 6182 | VAV3 levels | GCST90471030 | 0.71 |
| 6183 | Dermatophytosis / Dermatomycosis (PheCode 110) | GCST90475560 | 0.71 |
| 6184 | GOLM2/STC1 ratio | GCST90314952 | 0.71 |
| 6185 | Blood cell traits latent factor 2 (red cell) | GCST90559244 | 0.71 |
| 6186 | Leg fat-free mass (right) | Impedance measures | UKBB00000394 | 0.71 |
| 6187 | Spatial QRS-T angle | GCST90246320 | 0.71 |
| 6188 | MAP4K5/TBCB ratio | GCST90315384 | 0.71 |
| 6189 | red blood cell count (RBC, mean, inv-norm transformed) | GCST90476349 | 0.71 |
| 6190 | Operation code - anterior/posterior repair bladder/uterus | Operations | UKBB00000548 | 0.71 |
| 6191 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 90) | GCST90320909 | 0.71 |
| 6192 | Bifidobacterium catenulatum abundance in stool | GCST90032224 | 0.71 |
| 6193 | aparc-pial rh area lateralorbitofrontal | GCST90003185 | 0.71 |
| 6194 | RTN4IP1 levels | GCST90470507 | 0.70 |
| 6195 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T150 | ECGU000150 | 0.70 |
| 6196 | CD300A levels | GCST90468619 | 0.70 |
| 6197 | Linoleic acid to total fatty acids percentage | GCST90502025 | 0.70 |
| 6198 | NUDC levels | GCST90470102 | 0.70 |
| 6199 | RAPGEF2 levels | GCST90470426 | 0.70 |
| 6200 | APBB1IP levels | GCST90468327 | 0.70 |
| 6201 | Glycine levels | GCST90497315 | 0.70 |
| 6202 | aparc-pial rh area postcentral | GCST90003195 | 0.70 |
| 6203 | Body fat percentage (UKB data field 23099) | GCST90468160 | 0.70 |
| 6204 | Postinflammatory pulmonary fibrosis (PheCode 502) | GCST90476032 | 0.70 |
| 6205 | Speech-in-noise perception | GCST90044776 | 0.70 |
| 6206 | High cholesterol | GCST90475203 | 0.70 |
| 6207 | rfMRI amplitudes (ICA100 node 44) | GCST90004632 | 0.70 |
| 6208 | CCL17 levels | GCST90468569 | 0.69 |
| 6209 | OLR1 levels | GCST90470122 | 0.69 |
| 6210 | CUZD1 levels | GCST90468919 | 0.69 |
| 6211 | Total protein levels | UKBB00000826 | 0.69 |
| 6212 | APEX1 levels | GCST90468329 | 0.69 |
| 6213 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T167 | ECGU000167 | 0.69 |
| 6214 | IGDCC4 levels | GCST90469523 | 0.69 |
| 6215 | HTRA2/SIAE ratio | GCST90315097 | 0.69 |
| 6216 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T324 | ECGU000324 | 0.69 |
| 6217 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T105 | ECGA000105 | 0.69 |
| 6218 | Type 2 diabetes, wide definition | FING00001383 | 0.69 |
| 6219 | aseg rh volume Amygdala | GCST90002642 | 0.69 |
| 6220 | IMMT levels | GCST90469609 | 0.69 |
| 6221 | Total free cholesterol levels | GCST90500063 | 0.69 |
| 6222 | NADK levels | GCST90469993 | 0.69 |
| 6223 | KIFBP/LYN ratio | GCST90315246 | 0.69 |
| 6224 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T238 | ECGA000238 | 0.69 |
| 6225 | Placental weight (maternal genotype, adjusted for sex) | GCST90275198 | 0.69 |
| 6226 | F2R/GP6 ratio | GCST90314730 | 0.69 |
| 6227 | IDP dMRI ProbtrackX ISOVF atr l | GCST90004527 | 0.69 |
| 6228 | LCN15 levels | GCST90469746 | 0.69 |
| 6229 | SOST/SPP1 ratio | GCST90315871 | 0.69 |
| 6230 | CD163/MARCO ratio | GCST90313737 | 0.69 |
| 6231 | TREML1 levels | GCST90470961 | 0.69 |
| 6232 | Epiandrosterone sulfate levels | GCST90199752 | 0.69 |
| 6233 | aparc-Desikan lh thickness lateraloccipital | GCST90003455 | 0.69 |
| 6234 | Liver volume | GCST90016666 | 0.69 |
| 6235 | Bone marrow fat fraction of left proximal femur | GCST90652392 | 0.69 |
| 6236 | Urate | Blood biochemistry | UKBB00000884 | 0.68 |
| 6237 | Neutrophil count | GCST90018748 | 0.68 |
| 6238 | Right-hemisphere dorsal attention network to thalamus white-matter structural connectivity | GCST90302806 | 0.68 |
| 6239 | KYNU levels | GCST90469722 | 0.68 |
| 6240 | aseg lh intensity Thalamus-Proper | GCST90003768 | 0.68 |
| 6241 | CD27/CD79B ratio | GCST90313770 | 0.68 |
| 6242 | MPIG6B levels | GCST90469935 | 0.68 |
| 6243 | Cholesterol to Total Lipids in Large LDL percentage | GCST90497938 | 0.68 |
| 6244 | HAVCR2 levels | GCST90421515 | 0.68 |
| 6245 | Drink temperature | GCST90133002 | 0.68 |
| 6246 | Phosphate | Blood biochemistry | UKBB00000644 | 0.68 |
| 6247 | Phosphatidylcholine_34:2_[M+H]1+/Phosphatidylethanolamine_37:2_[M+H]1+/Phosphatidate_39:3_[M+NH4]1+ levels | GCST90060303 | 0.68 |
| 6248 | NTRK3 levels | GCST90470098 | 0.68 |
| 6249 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T304 | ECGU000304 | 0.68 |
| 6250 | IDP dMRI TBSS ICVF Anterior corona radiata R | GCST90004349 | 0.68 |
| 6251 | MYOC/RGMB ratio | GCST90315508 | 0.67 |
| 6252 | Mean time to correctly identify matches | Reaction time | UKBB00000453 | 0.67 |
| 6253 | CXCL17 levels | GCST90468929 | 0.67 |
| 6254 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T233 | ECGU000233 | 0.67 |
| 6255 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T323 | ECGU000323 | 0.67 |
| 6256 | Type 1 diabetes | GCST90432066 | 0.67 |
| 6257 | HippSubfield lh volume GC-ML-DG-head | GCST90002679 | 0.67 |
| 6258 | Ischemic heart disease (PheCode 411) | GCST008370 | 0.67 |
| 6259 | CX3CL1/LAYN ratio | GCST90314325 | 0.67 |
| 6260 | Diabetes mellitus | endocrine/metabolic | UKBB00000169 | 0.67 |
| 6261 | Pulse wave Arterial Stiffness index | Arterial stiffness | UKBB00000724 | 0.67 |
| 6262 | Alanine aminotransferase levels | GCST90025979 | 0.67 |
| 6263 | Main speciality of consultant (recoded) - General surgery | Summary Administration | UKBB00000417 | 0.66 |
| 6264 | Operative procedures - Angiocardiography of left side of heart NEC | Summary Operations | UKBB00000572 | 0.66 |
| 6265 | Variation in diet | Diet | UKBB00000892 | 0.66 |
| 6266 | LAT/MANF ratio | GCST90315284 | 0.66 |
| 6267 | Barrett's esophagus | GCST90000515 | 0.66 |
| 6268 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T194 | ECGA000194 | 0.66 |
| 6269 | CD276 levels | GCST90468614 | 0.66 |
| 6270 | CXCL5/SDC4 ratio | GCST90314353 | 0.66 |
| 6271 | MEP1B levels | GCST90469888 | 0.66 |
| 6272 | SCARF1/SUSD1 ratio | GCST90315811 | 0.66 |
| 6273 | SEMA4C levels | GCST90470572 | 0.66 |
| 6274 | Current employment status - In paid employment or self-employed | Employment | UKBB00000158 | 0.66 |
| 6275 | IDP T1 FAST ROIs V cerebellum crus II | GCST90002573 | 0.66 |
| 6276 | DAG1/DBNL ratio | GCST90314372 | 0.66 |
| 6277 | ANGPT2 levels | GCST90468301 | 0.66 |
| 6278 | Pulse rate (UKB data field 102) | GCST90468177 | 0.66 |
| 6279 | AKT2 levels | GCST90468277 | 0.66 |
| 6280 | AXL levels | GCST90468406 | 0.65 |
| 6281 | MMP8 levels | GCST90469922 | 0.65 |
| 6282 | Non-cancer illness code, self-reported - type 2 diabetes | Medical conditions | UKBB00000522 | 0.65 |
| 6283 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T314 | ECGA000314 | 0.65 |
| 6284 | SERPINE1/VASH1 ratio | GCST90315836 | 0.65 |
| 6285 | DTI TBSS MD Posterior limb of internal capsule R | GCST90384590 | 0.65 |
| 6286 | PEAR1/SPINT2 ratio | GCST90315644 | 0.65 |
| 6287 | Right-hemisphere visual network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302775 | 0.65 |
| 6288 | aparc-DKTatlas lh thickness precuneus | GCST90003563 | 0.65 |
| 6289 | GDF2 levels | GCST90469322 | 0.65 |
| 6290 | Triacylglycerol (54:0) [NL-18:0] levels | GCST90025173 | 0.65 |
| 6291 | Height | GCST90278637 | 0.65 |
| 6292 | Non-cancer illness code, self-reported - heart attack/myocardial infarction | Medical conditions | UKBB00000514 | 0.65 |
| 6293 | FGFR2 levels | GCST90469233 | 0.65 |
| 6294 | MYOC levels | GCST90469983 | 0.65 |
| 6295 | IDP dMRI ProbtrackX L3 str r | GCST90004324 | 0.65 |
| 6296 | PDGFC levels | GCST90470190 | 0.65 |
| 6297 | Disorders of skin appendages | FING00000460 | 0.64 |
| 6298 | Osteoarthritis | GCST90134288 | 0.64 |
| 6299 | wg rh intensity-contrast supramarginal | GCST90003857 | 0.64 |
| 6300 | Smoking and associated risk behaviours (confirmatory factor analysis Factor 6) | GCST90309341 | 0.64 |
| 6301 | Sphingomyelin_32:1_[M+H]1+ levels | GCST90060225 | 0.64 |
| 6302 | Belief that own life is meaningful | Happiness and subjective well-being | UKBB00000090 | 0.64 |
| 6303 | Appendicular lean mass | GCST90000027 | 0.64 |
| 6304 | CD69/PLXNB3 ratio | GCST90313881 | 0.64 |
| 6305 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T155 | ECGU000155 | 0.64 |
| 6306 | APRT/CD63 ratio | GCST90313334 | 0.64 |
| 6307 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T307 | ECGA000307 | 0.64 |
| 6308 | Red blood cell count | GCST90018751 | 0.64 |
| 6309 | HPCAL1/LAT ratio | GCST90315072 | 0.64 |
| 6310 | DTI TBSS MD Cingulum hippocampus L | GCST90384609 | 0.64 |
| 6311 | ADGRB3 levels | GCST90468234 | 0.64 |
| 6312 | Tea intake (UKB data field 1488) | GCST90132983 | 0.64 |
| 6313 | LTBP2/MYOC ratio | GCST90315337 | 0.64 |
| 6314 | Keratoconus | FING00000709 | 0.64 |
| 6315 | Lactose intolerance, other/unspecified | FING00000712 | 0.64 |
| 6316 | PTPN6/SNAP23 ratio | GCST90315747 | 0.64 |
| 6317 | IDP dMRI TBSS L3 Posterior corona radiata R | GCST90004197 | 0.64 |
| 6318 | PI16 levels | GCST90470229 | 0.64 |
| 6319 | DKK1/LGALS8 ratio | GCST90314472 | 0.64 |
| 6320 | DNPH1/NSFL1C ratio | GCST90314526 | 0.63 |
| 6321 | NFKBIE levels | GCST90470039 | 0.63 |
| 6322 | ENO2/FXYD5 ratio | GCST90314659 | 0.63 |
| 6323 | F11R/TMSB10 ratio | GCST90314729 | 0.63 |
| 6324 | Biological Father: Chronic Lung Disease including COPD, Emphysema or Bronchitis | GCST90475247 | 0.63 |
| 6325 | CRADD/EREG ratio | GCST90314236 | 0.63 |
| 6326 | Osteopenia or other disorder of bone and cartilage (PheCode 743.9) | GCST90476261 | 0.63 |
| 6327 | Bone marrow fat fraction of lumbar vertebra 2 | GCST90652387 | 0.63 |
| 6328 | MTSS1 levels | GCST90469960 | 0.63 |
| 6329 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T445 | ECGU000445 | 0.63 |
| 6330 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T323 | ECGA000323 | 0.63 |
| 6331 | EGF/PPIB ratio | GCST90314612 | 0.63 |
| 6332 | PILRA levels | GCST90470236 | 0.63 |
| 6333 | CD164/SIAE ratio | GCST90313744 | 0.63 |
| 6334 | Operative procedures - Insertion of prosthetic replacement for lens NEC | Summary Operations | UKBB00000583 | 0.63 |
| 6335 | CXCL10/CXCL11 ratio | GCST90314330 | 0.63 |
| 6336 | CDH5/TEK ratio | GCST90313961 | 0.63 |
| 6337 | Basal metabolic rate | Impedance measures | UKBB00000086 | 0.63 |
| 6338 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T482 | ECGA000482 | 0.63 |
| 6339 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T444 | ECGU000444 | 0.63 |
| 6340 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T137 | ECGU000137 | 0.63 |
| 6341 | Principal component-derived dietary pattern 35 | GCST90133040 | 0.63 |
| 6342 | Percentage of invited food questionnaires completed | GCST90012790 | 0.63 |
| 6343 | AK1/NSFL1C ratio | GCST90313224 | 0.62 |
| 6344 | B4GALT1/B4GAT1 ratio | GCST90313429 | 0.62 |
| 6345 | CD22 levels | GCST90468610 | 0.62 |
| 6346 | IDP dMRI ProbtrackX ISOVF str r | GCST90004549 | 0.62 |
| 6347 | COMP/MYOC ratio | GCST90314191 | 0.62 |
| 6348 | HippSubfield rh volume Whole-hippocampus | GCST90002711 | 0.62 |
| 6349 | Comorbidity of gastric and duodenal ulcers | GCST90270929 | 0.62 |
| 6350 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 6) | GCST90320569 | 0.62 |
| 6351 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T222 | ECGU000222 | 0.62 |
| 6352 | Alanine levels | GCST90497086 | 0.62 |
| 6353 | Dried fruit liking | GCST90094756 | 0.62 |
| 6354 | Coronary atherosclerosis (PheCode 411.4) | GCST90043957 | 0.62 |
| 6355 | Parkinson's disease or first degree relation to individual with Parkinson's disease | GCST009325 | 0.62 |
| 6356 | CCL16 levels | GCST90179243 | 0.62 |
| 6357 | Blood cell traits latent factor 1 (white cell) | GCST90559243 | 0.62 |
| 6358 | CGREF1/FAM3C ratio | GCST90314032 | 0.62 |
| 6359 | Sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) levels | GCST90200033 | 0.62 |
| 6360 | FOXO3/SH2B3 ratio | GCST90314881 | 0.62 |
| 6361 | MOG/RTBDN ratio | GCST90315476 | 0.62 |
| 6362 | Fracture of forearm | FING00000554 | 0.62 |
| 6363 | CD74/LILRB4 ratio | GCST90313894 | 0.62 |
| 6364 | ALCAM/MSR1 ratio | GCST90313240 | 0.61 |
| 6365 | Hot drink temperature | Diet | UKBB00000329 | 0.61 |
| 6366 | rfMRI amplitudes (ICA100 node 28) | GCST90004616 | 0.61 |
| 6367 | wg rh intensity-contrast lateralorbitofrontal | GCST90003838 | 0.61 |
| 6368 | GFER/MAVS ratio | GCST90314919 | 0.61 |
| 6369 | DTI autoptx L2 str l tract | GCST90385189 | 0.61 |
| 6370 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T242 | ECGU000242 | 0.61 |
| 6371 | Serum creatinine levels | GCST90018759 | 0.61 |
| 6372 | FTCD levels | GCST90469274 | 0.61 |
| 6373 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T58 | ECGA000058 | 0.61 |
| 6374 | Mild obesity-related type 2 diabetes | GCST90026415 | 0.61 |
| 6375 | Height (maximum, inv-normal transformed) | GCST90475359 | 0.61 |
| 6376 | ACOT13 levels | GCST90468200 | 0.61 |
| 6377 | CXCL5 levels | GCST90468932 | 0.61 |
| 6378 | Hematocrit | GCST90018740 | 0.61 |
| 6379 | Leg fat mass (right) | Impedance measures | UKBB00000390 | 0.61 |
| 6380 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 11) | GCST90320574 | 0.61 |
| 6381 | Treatment speciality of consultant (recoded) - Dermatology | Summary Administration | UKBB00000830 | 0.61 |
| 6382 | IGF2R/LGMN ratio | GCST90315131 | 0.61 |
| 6383 | Hypothyroidism | GCST90018642 | 0.61 |
| 6384 | Severe hearing loss or partial deafness in one or both ears | GCST90475385 | 0.61 |
| 6385 | Right hippocampal volume (tail) | GCST90267973 | 0.61 |
| 6386 | Gut microbiota abundance (k_Bacteria.p_Bacteroidetes.c_Bacteroidia.o_Bacteroidales.f_Rikenellaceae.g_Alistipes) | GCST90027701 | 0.61 |
| 6387 | SLC27A4 levels | GCST90470657 | 0.61 |
| 6388 | CEP43/WASF1 ratio | GCST90314023 | 0.60 |
| 6389 | Other contact dermatitis | FING00000990 | 0.60 |
| 6390 | CFHR5 levels | GCST90468728 | 0.60 |
| 6391 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T443 | ECGU000443 | 0.60 |
| 6392 | ANGPT1/CCN2 ratio | GCST90313261 | 0.60 |
| 6393 | THPO levels | GCST90470857 | 0.60 |
| 6394 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T442 | ECGU000442 | 0.60 |
| 6395 | SFTPA2 levels | GCST90470613 | 0.60 |
| 6396 | ADA levels | GCST90468231 | 0.60 |
| 6397 | Squamous cell carcinoma (MTAG) | GCST90137412 | 0.60 |
| 6398 | ARHGAP45 levels | GCST90468355 | 0.60 |
| 6399 | BACH1/CD2AP ratio | GCST90313435 | 0.60 |
| 6400 | FAM20A levels | GCST90469185 | 0.60 |
| 6401 | SRC/TBL1X ratio | GCST90315884 | 0.60 |
| 6402 | NOTCH3/PTPRS ratio | GCST90315547 | 0.60 |
| 6403 | Acetoacetate levels (UKB data field 23476) | GCST90269573 | 0.60 |
| 6404 | ABL1 levels | GCST90468190 | 0.60 |
| 6405 | DTI TBSS L3 Posterior thalamic radiation R | GCST90384552 | 0.60 |
| 6406 | Functional digestive disorders | digestive | UKBB00000274 | 0.60 |
| 6407 | CRELD1 levels | GCST90468858 | 0.60 |
| 6408 | Raw vegetable consumption | GCST90132978 | 0.60 |
| 6409 | CR2 levels | GCST90468852 | 0.59 |
| 6410 | Duodenal ulcer | GCST90270928 | 0.59 |
| 6411 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T422 | ECGU000422 | 0.59 |
| 6412 | T1 FreeSurfer DKT rh lateraloccipital area | GCST90384295 | 0.59 |
| 6413 | aparc-a2009s rh volume G-front-inf-Triangul | GCST90003012 | 0.59 |
| 6414 | White blood cell count | GCST90002375 | 0.59 |
| 6415 | Heel bone mineral density (BMD) (left) | Bone-densitometry of heel | UKBB00000313 | 0.59 |
| 6416 | IDP dMRI TBSS MD Genu of corpus callosum | GCST90004029 | 0.59 |
| 6417 | Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications | GCST90093113 | 0.59 |
| 6418 | DTI TBSS L2 Anterior corona radiata L | GCST90384499 | 0.59 |
| 6419 | Alanine transaminase (ALT, minimum, inv-norm transformed) | GCST90475115 | 0.59 |
| 6420 | CEACAM20 levels | GCST90468693 | 0.59 |
| 6421 | NECTIN2/SPON2 ratio | GCST90315530 | 0.59 |
| 6422 | wg rh intensity-contrast medialorbitofrontal | GCST90003840 | 0.59 |
| 6423 | IDP dMRI TBSS ISOVF Superior corona radiata R | GCST90004501 | 0.59 |
| 6424 | Takes medication for Sleep apnea? | GCST90475258 | 0.59 |
| 6425 | CXCL16 levels | GCST90012059 | 0.59 |
| 6426 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T309 | ECGA000309 | 0.59 |
| 6427 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T116 | ECGU000116 | 0.59 |
| 6428 | Heel bone mineral density (BMD) T-score, automated (left) | Bone-densitometry of heel | UKBB00000316 | 0.59 |
| 6429 | Heel quantitative ultrasound index (QUI), direct entry (left) | Bone-densitometry of heel | UKBB00000322 | 0.59 |
| 6430 | IDP dMRI TBSS FA External capsule L | GCST90003910 | 0.59 |
| 6431 | IDP dMRI TBSS ICVF Retrolenticular part of internal capsule R | GCST90004347 | 0.59 |
| 6432 | FOXO1/MAP4K5 ratio | GCST90314872 | 0.59 |
| 6433 | ADAM22 levels | GCST90468218 | 0.59 |
| 6434 | Diabetes / Sugar | GCST90475265 | 0.59 |
| 6435 | CA2/TGM2 ratio | GCST90313582 | 0.59 |
| 6436 | HEXIM1/IPCEF1 ratio | GCST90315046 | 0.59 |
| 6437 | Total body bone mineral density (age 45-60) | GCST005350 | 0.59 |
| 6438 | Diverticulosis (PheCode 562.1) | GCST90476076 | 0.58 |
| 6439 | KLK7 levels | GCST90469706 | 0.58 |
| 6440 | IDP dMRI TBSS L2 Retrolenticular part of internal capsule L | GCST90004144 | 0.58 |
| 6441 | Biological Mother: Cancer, Skin | GCST90475487 | 0.58 |
| 6442 | Impedance of arm (left) | Impedance measures | UKBB00000356 | 0.58 |
| 6443 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T299 | ECGA000299 | 0.58 |
| 6444 | Neurofibromatosis, type 2 | FING00000867 | 0.58 |
| 6445 | Atrial fibrillation and flutter | Other forms of heart disease | UKBB00000056 | 0.58 |
| 6446 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T191 | ECGA000191 | 0.58 |
| 6447 | X-12707 levels | GCST90200502 | 0.58 |
| 6448 | Cognitive processing accuracy | GCST90446169 | 0.58 |
| 6449 | EIF4B/MAP4K5 ratio | GCST90314623 | 0.58 |
| 6450 | Biliary cirrhosis, NAS | FING00000213 | 0.58 |
| 6451 | Docosahexaenoic acid to total fatty acids percentage | GCST90501999 | 0.58 |
| 6452 | Childhood sunburn occasions | Sun exposure | UKBB00000130 | 0.58 |
| 6453 | Drinks usually with meals in current drinkers (yes vs no) (UKB data field 1618) | GCST90132926 | 0.58 |
| 6454 | RBP5 levels | GCST90470439 | 0.58 |
| 6455 | Left-hemisphere limbic network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302732 | 0.58 |
| 6456 | ANGPT1/APP ratio | GCST90313260 | 0.58 |
| 6457 | Operative procedures - Fibreoptic endoscopic examination of upper gastrointestinal tract and biopsy of lesion of upper gastrointestinal tract | Summary Operations | UKBB00000578 | 0.58 |
| 6458 | RETN levels | GCST90470457 | 0.58 |
| 6459 | Appendicular lean mass | GCST90000025 | 0.58 |
| 6460 | Substance use, excluding alcohol | FING00001342 | 0.58 |
| 6461 | DBNL levels | GCST90468951 | 0.58 |
| 6462 | Ever unenthusiastic/disinterested for a whole week | Mental health | UKBB00000226 | 0.58 |
| 6463 | Anemia of chronic disease (PheCode 285.2) | GCST90475790 | 0.58 |
| 6464 | Brainstem global volume Medulla | GCST90002764 | 0.57 |
| 6465 | IGFBPL1 levels | GCST90469533 | 0.57 |
| 6466 | Endometriosis | FING00000497 | 0.57 |
| 6467 | PTS levels | GCST90470390 | 0.57 |
| 6468 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T303 | ECGU000303 | 0.57 |
| 6469 | rfMRI amplitudes (ICA100 node 40) | GCST90004628 | 0.57 |
| 6470 | Principal component-derived dietary pattern 2 | GCST90133007 | 0.57 |
| 6471 | ERBB4 levels | GCST90469141 | 0.57 |
| 6472 | LGALS9/SIGLEC1 ratio | GCST90315323 | 0.57 |
| 6473 | Prescriptions - gliclazide | sulfonylurea,diabetes | UKBB00000684 | 0.57 |
| 6474 | Intra-ocular pressure, corneal-compensated (right) | Intraocular pressure | UKBB00000375 | 0.57 |
| 6475 | F-strong flavour liking (derived food-liking factor) | GCST90094851 | 0.57 |
| 6476 | Valine levels | GCST90243453 | 0.57 |
| 6477 | MTSS2 levels | GCST90469961 | 0.57 |
| 6478 | MSRA/SNAP29 ratio | GCST90315500 | 0.57 |
| 6479 | Chronic pain (confirmatory factor analysis Factor 18) | GCST90309352 | 0.57 |
| 6480 | TIMP1 levels | GCST90470869 | 0.57 |
| 6481 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T302 | ECGU000302 | 0.57 |
| 6482 | IDP dMRI TBSS L3 Uncinate fasciculus R | GCST90004215 | 0.57 |
| 6483 | DTI TBSS FA Corticospinal tract R | GCST90384386 | 0.57 |
| 6484 | CPXM1/VEGFC ratio | GCST90314223 | 0.57 |
| 6485 | IDP T1 FAST ROIs R caudate | GCST90002550 | 0.57 |
| 6486 | Leg fat-free mass (left) | Impedance measures | UKBB00000393 | 0.57 |
| 6487 | Omega-3 fatty acids to total fatty acids percentage | GCST90502466 | 0.57 |
| 6488 | GGT1/IL1RL2 ratio | GCST90314929 | 0.57 |
| 6489 | Tea intake | Diet | UKBB00000814 | 0.57 |
| 6490 | EPHB6/LAYN ratio | GCST90314681 | 0.57 |
| 6491 | F-fatty/salty food liking (derived food-liking factor) | GCST90094759 | 0.57 |
| 6492 | aparc-DKTatlas rh area supramarginal | GCST90003294 | 0.56 |
| 6493 | Trunk fat mass (UKB data field 23128) | GCST90468180 | 0.56 |
| 6494 | CLC/RNASE3 ratio | GCST90314077 | 0.56 |
| 6495 | BLMH/SERPINE1 ratio | GCST90313520 | 0.56 |
| 6496 | C2 levels | GCST90468497 | 0.56 |
| 6497 | Thoracic aortic aneurysm | FING00001357 | 0.56 |
| 6498 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T460 | ECGU000460 | 0.56 |
| 6499 | ROBO1/SPON1 ratio | GCST90315783 | 0.56 |
| 6500 | CD69/TIA1 ratio | GCST90313888 | 0.56 |
| 6501 | Sleep apnoea | FING00001309 | 0.56 |
| 6502 | IDP dMRI TBSS ICVF Posterior thalamic radiation L | GCST90004356 | 0.56 |
| 6503 | Principal component-derived dietary pattern 12 | GCST90133017 | 0.56 |
| 6504 | EIF3J levels | GCST90241122 | 0.56 |
| 6505 | F7/PROC ratio | GCST90314744 | 0.56 |
| 6506 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T293 | ECGA000293 | 0.56 |
| 6507 | NAAA levels | GCST90469991 | 0.56 |
| 6508 | PGD levels | GCST90470217 | 0.56 |
| 6509 | SERPINB8 levels | GCST90470592 | 0.56 |
| 6510 | Leg predicted mass (left) | Impedance measures | UKBB00000396 | 0.55 |
| 6511 | Hair colour (natural, before greying): Blonde (UKB data field 1747_1) | GCST90041836 | 0.55 |
| 6512 | Hidradenitis suppurativa | FING00000621 | 0.55 |
| 6513 | PPIF levels | GCST90470293 | 0.55 |
| 6514 | aseg rh intensity Caudate | GCST90003783 | 0.55 |
| 6515 | Vascular dementia (subcortical) | FING00001420 | 0.55 |
| 6516 | A body shape index | GCST012231 | 0.55 |
| 6517 | IDP dMRI TBSS FA Uncinate fasciculus R | GCST90003921 | 0.55 |
| 6518 | PRSS53 levels | GCST90470344 | 0.55 |
| 6519 | EGFR/MEGF9 ratio | GCST90314614 | 0.55 |
| 6520 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T121 | ECGU000121 | 0.55 |
| 6521 | Contracture of palmar fascia [Dupuytren's disease] | musculoskeletal | UKBB00000146 | 0.55 |
| 6522 | IDP dMRI ProbtrackX ISOVF unc r | GCST90004551 | 0.55 |
| 6523 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T313 | ECGA000313 | 0.55 |
| 6524 | height (mean, inv-normal transformed) | GCST90475362 | 0.55 |
| 6525 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T485 | ECGA000485 | 0.55 |
| 6526 | CANT1/GSTA1 ratio | GCST90313616 | 0.55 |
| 6527 | GBA1 levels | GCST90423262 | 0.55 |
| 6528 | WFDC12 levels | GCST90471073 | 0.55 |
| 6529 | Left-hemisphere dorsal attention network to putamen white-matter structural connectivity | GCST90302703 | 0.55 |
| 6530 | EPS8L2/LGALS4 ratio | GCST90314685 | 0.55 |
| 6531 | IDP dMRI TBSS L2 Sagittal stratum L | GCST90004154 | 0.55 |
| 6532 | aparc-pial rh area fusiform | GCST90003180 | 0.55 |
| 6533 | Carotid intima-media thickness (MTAG) | GCST90449061 | 0.55 |
| 6534 | Chronic venous insufficiency [CVI] (PheCode 456) | GCST90476016 | 0.55 |
| 6535 | TACC3 levels | GCST90470797 | 0.55 |
| 6536 | NECTIN2/NPDC1 ratio | GCST90315528 | 0.55 |
| 6537 | IDP dMRI TBSS L1 Retrolenticular part of internal capsule R | GCST90004095 | 0.55 |
| 6538 | PAPPA levels | GCST90012036 | 0.55 |
| 6539 | Gut microbiota abundance (k_Bacteria.p_Bacteroidetes.c_Bacteroidia.o_Bacteroidales.f_Rikenellaceae) | GCST90027668 | 0.55 |
| 6540 | PDGFB/SPINT2 ratio | GCST90315629 | 0.55 |
| 6541 | Osteoarthrosis (PheCode 740) | GCST90476253 | 0.55 |
| 6542 | HYOU1 levels | GCST90469496 | 0.55 |
| 6543 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T449 | ECGU000449 | 0.55 |
| 6544 | LRRC59 levels | GCST90469804 | 0.54 |
| 6545 | Urinary incontinence (PheCode 599.4) | GCST90476152 | 0.54 |
| 6546 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 105) | GCST90320924 | 0.54 |
| 6547 | IMPA1 levels | GCST90469610 | 0.54 |
| 6548 | ENAH levels | GCST90469106 | 0.54 |
| 6549 | PHACTR2 levels | GCST90470224 | 0.54 |
| 6550 | DKK4/REG1B ratio | GCST90314490 | 0.54 |
| 6551 | Cutaneous abscess, furuncle and carbuncle | FING00000373 | 0.54 |
| 6552 | CALCOCO1/VPS53 ratio | GCST90313612 | 0.54 |
| 6553 | PSIP1 levels | GCST90470354 | 0.54 |
| 6554 | IDP dMRI TBSS MD Posterior corona radiata R | GCST90004053 | 0.54 |
| 6555 | LCN2 levels | GCST90469747 | 0.54 |
| 6556 | RABEP1 levels | GCST90470414 | 0.54 |
| 6557 | IL17D levels | GCST90469560 | 0.54 |
| 6558 | Spread type: Flora Pro-Active/Benecol (UKB data field 1428_2) | GCST90132957 | 0.54 |
| 6559 | IDP dMRI TBSS L3 Superior longitudinal fasciculus R | GCST90004211 | 0.54 |
| 6560 | Margaroylcarnitine (C17) levels | GCST90199929 | 0.54 |
| 6561 | Phosphatidylcholine_34:0_[M+H]1+/Phosphatidylethanolamine_37:0_[M+H]1+/Phosphatidate_39:1_[M+NH4]1+ levels | GCST90060311 | 0.54 |
| 6562 | Medical abortion | FING00000796 | 0.54 |
| 6563 | rfMRI connectivity (ICA100 edge 659) | GCST90005512 | 0.54 |
| 6564 | Retinal thickness (functional principal component 3) | GCST90455723 | 0.54 |
| 6565 | ASAH2 levels | GCST90242098 | 0.54 |
| 6566 | Left-hemisphere default mode network to right-hemisphere visual network white-matter structural connectivity | GCST90302760 | 0.54 |
| 6567 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T160 | ECGU000160 | 0.54 |
| 6568 | RNF41/WWP2 ratio | GCST90315782 | 0.54 |
| 6569 | Arm fat-free mass (left) | Impedance measures | UKBB00000047 | 0.54 |
| 6570 | Plasma argininate* levels in chronic kidney disease | GCST90264826 | 0.54 |
| 6571 | Phenylalanine levels (UKB data field 23468) | GCST90269565 | 0.54 |
| 6572 | Tyrosine levels | GCST90092993 | 0.54 |
| 6573 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T448 | ECGU000448 | 0.54 |
| 6574 | ANXA4/LACTB2 ratio | GCST90313293 | 0.54 |
| 6575 | IDP dMRI ProbtrackX ISOVF slf r | GCST90004547 | 0.54 |
| 6576 | DPEP1 levels | GCST90469030 | 0.53 |
| 6577 | CDH17/PTPRM ratio | GCST90313943 | 0.53 |
| 6578 | Left ventricular end-systolic volume | GCST90268126 | 0.53 |
| 6579 | BA-exvivo rh area BA4a | GCST90003225 | 0.53 |
| 6580 | Body fat percentage (adjusted for testosterone and SHBG) x sex interaction | GCST90432181 | 0.53 |
| 6581 | ANPEP/CXADR ratio | GCST90313272 | 0.53 |
| 6582 | ITIH4 levels | GCST90469651 | 0.53 |
| 6583 | AXIN1/ITGB1BP2 ratio | GCST90313412 | 0.53 |
| 6584 | CRYZL1 levels | GCST90468878 | 0.53 |
| 6585 | CEBPB levels | GCST90468700 | 0.53 |
| 6586 | IDP dMRI TBSS L3 Superior corona radiata L | GCST90004196 | 0.53 |
| 6587 | DTI TBSS MD Superior longitudinal fasciculus R | GCST90384612 | 0.53 |
| 6588 | Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers) | FING00000766 | 0.53 |
| 6589 | GOLM2 levels | GCST90469376 | 0.53 |
| 6590 | Chronotype | GCST003837 | 0.53 |
| 6591 | ITGB1/VASN ratio | GCST90315232 | 0.53 |
| 6592 | CD74/IL18BP ratio | GCST90313892 | 0.53 |
| 6593 | Modified Stumvoll Insulin Sensitivity Index | GCST90267574 | 0.53 |
| 6594 | Pain in limb (PheCode 773) | GCST90476270 | 0.53 |
| 6595 | NECTIN4/SPINK5 ratio | GCST90315534 | 0.53 |
| 6596 | ADGRE2 levels | GCST90468237 | 0.52 |
| 6597 | Secondary thrombocytopenia (PheCode 287.32) | GCST90475810 | 0.52 |
| 6598 | PLB1 levels | GCST90470253 | 0.52 |
| 6599 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T102 | ECGA000102 | 0.52 |
| 6600 | Occupational attainment | GCST90102253 | 0.52 |
| 6601 | CXADR levels | GCST90468922 | 0.52 |
| 6602 | Right-hemisphere visual network to right-hemisphere default mode network white-matter structural connectivity | GCST90302780 | 0.52 |
| 6603 | NAGPA levels | GCST90469996 | 0.52 |
| 6604 | VEGFA levels | GCST90471034 | 0.52 |
| 6605 | Age first had sexual intercourse | Sexual factors | UKBB00000014 | 0.52 |
| 6606 | ALPP/LAMP3 ratio | GCST90313249 | 0.52 |
| 6607 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T300 | ECGA000300 | 0.52 |
| 6608 | Presence of cardiac and vascular implants and grafts | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000708 | 0.52 |
| 6609 | aparc-DKTatlas rh thickness paracentral | GCST90003586 | 0.52 |
| 6610 | Cereal type: Muesli (UKB data field 1468_4) | GCST90132972 | 0.52 |
| 6611 | BLNK levels | GCST90468448 | 0.52 |
| 6612 | Enterocolitis due to Clostridium difficile | FING00000507 | 0.52 |
| 6613 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 33) | GCST90320596 | 0.52 |
| 6614 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 106) | GCST90320925 | 0.52 |
| 6615 | DTI autoptx L1 atr l tract | GCST90385141 | 0.51 |
| 6616 | IQGAP2/STX4 ratio | GCST90315190 | 0.51 |
| 6617 | POF1B levels | GCST90470281 | 0.51 |
| 6618 | BMP7 levels | GCST90088157 | 0.51 |
| 6619 | Ulcerative proctitis | FING00001393 | 0.51 |
| 6620 | aparc-DKTatlas rh volume supramarginal | GCST90002922 | 0.51 |
| 6621 | Blood urea nitrogen (BUN, minimum, inv-norm transformed) | GCST90475168 | 0.51 |
| 6622 | MUC13 levels | GCST90469963 | 0.51 |
| 6623 | ACADSB levels | GCST90468195 | 0.51 |
| 6624 | DPP6/NRCAM ratio | GCST90314542 | 0.51 |
| 6625 | MMP9/OSM ratio | GCST90315468 | 0.51 |
| 6626 | rfMRI connectivity ICA-features 2 | GCST90006340 | 0.51 |
| 6627 | LGALS3 levels | GCST90179303 | 0.51 |
| 6628 | Posterior thigh muscle fat infiltration percentage | GCST90267355 | 0.51 |
| 6629 | T1 FreeSurfer aseg Left-Lateral-Ventricle | GCST90384139 | 0.51 |
| 6630 | CPB1/CTRC ratio | GCST90314209 | 0.51 |
| 6631 | PAPL levels | GCST90427208 | 0.51 |
| 6632 | Aniseed liking | GCST90094689 | 0.51 |
| 6633 | F-lentils/beans liking (derived food-liking factor) | GCST90094793 | 0.51 |
| 6634 | PLAT levels | GCST90470250 | 0.51 |
| 6635 | Lysophosphatidylcholine (26:0) [sn2] levels | GCST90024189 | 0.51 |
| 6636 | Fluid intelligence score decline (log-difference score) | GCST90565852 | 0.50 |
| 6637 | PTPN1/SCAMP3 ratio | GCST90315743 | 0.50 |
| 6638 | HBEGF/PDGFA ratio | GCST90315033 | 0.50 |
| 6639 | DTI TBSS L2 External capsule L | GCST90384509 | 0.50 |
| 6640 | MYCT1 levels | GCST90618046 | 0.50 |
| 6641 | Vegetables liking | GCST90094862 | 0.50 |
| 6642 | IDP dMRI TBSS L3 Posterior corona radiata L | GCST90004198 | 0.50 |
| 6643 | Calcific aortic valvular stenosis, operated | FING00000234 | 0.50 |
| 6644 | ZFYVE19 levels | GCST90471098 | 0.50 |
| 6645 | C1QA levels | GCST90468485 | 0.50 |
| 6646 | PXN levels | GCST90470396 | 0.50 |
| 6647 | AGRN/HSPG2 ratio | GCST90313201 | 0.50 |
| 6648 | Platelet count during postpartum period | GCST90302228 | 0.50 |
| 6649 | ERP29 levels | GCST90088843 | 0.50 |
| 6650 | aseg rh volume Hippocampus | GCST90002641 | 0.50 |
| 6651 | Ceramide (d18:2/22:0) levels | GCST90024682 | 0.50 |
| 6652 | PRKAR1A/SNAP23 ratio | GCST90315728 | 0.50 |
| 6653 | CLEC14A/EPHB4 ratio | GCST90314079 | 0.50 |
| 6654 | IDP T1 FIRST brain stem+4th ventricle volume | GCST90002450 | 0.50 |
| 6655 | Weight | Impedance measures | UKBB00000910 | 0.50 |
| 6656 | Orange juice liking | GCST90094806 | 0.49 |
| 6657 | IL1RL1 levels | GCST90241581 | 0.49 |
| 6658 | INPPL1 levels | GCST90469619 | 0.49 |
| 6659 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T192 | ECGA000192 | 0.49 |
| 6660 | Abnormal movement (PheCode 350) | GCST90475840 | 0.49 |
| 6661 | DPP10 levels | GCST90469032 | 0.49 |
| 6662 | Spinal stenosis | FING00001322 | 0.49 |
| 6663 | CD40LG/GP6 ratio | GCST90313822 | 0.49 |
| 6664 | GP1BA/SIAE ratio | GCST90314959 | 0.49 |
| 6665 | VCAM1 levels | GCST90471031 | 0.49 |
| 6666 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T308 | ECGA000308 | 0.49 |
| 6667 | Pollinosis | GCST90018683 | 0.49 |
| 6668 | APP levels | GCST90468344 | 0.49 |
| 6669 | CSF3R levels | GCST90468885 | 0.49 |
| 6670 | PAMR1/RARRES2 ratio | GCST90315595 | 0.49 |
| 6671 | Spicy food liking | GCST90094846 | 0.49 |
| 6672 | Serum 25-Hydroxyvitamin D level variance | GCST90000621 | 0.48 |
| 6673 | Fracture of forearm | GCST90281273 | 0.48 |
| 6674 | aparc-Desikan rh thickness paracentral | GCST90003495 | 0.48 |
| 6675 | IDP dMRI ProbtrackX L2 atr l | GCST90004275 | 0.48 |
| 6676 | AARSD1/UBAC1 ratio | GCST90313135 | 0.48 |
| 6677 | PPP2R5A levels | GCST90470306 | 0.48 |
| 6678 | T1 FreeSurfer DKT lh lateraloccipital area | GCST90384202 | 0.48 |
| 6679 | BACH1 levels | GCST90468415 | 0.48 |
| 6680 | IDP dMRI TBSS L2 Cingulum hippocampus R | GCST90004159 | 0.48 |
| 6681 | Glaucoma (primary open-angle) | GCST90011768 | 0.48 |
| 6682 | DKK4/REG1A ratio | GCST90314489 | 0.48 |
| 6683 | Breathing problems responsible for leaving job | Employment history | UKBB00000112 | 0.48 |
| 6684 | Tinnitus | GCST90448242 | 0.48 |
| 6685 | SDCCAG8 levels | GCST90470560 | 0.48 |
| 6686 | CD46/NECTIN2 ratio | GCST90313832 | 0.48 |
| 6687 | Left-hemisphere dorsal attention network to right-hemisphere default mode network white-matter structural connectivity | GCST90302700 | 0.48 |
| 6688 | Basal cell carcinoma | GCST90468114 | 0.48 |
| 6689 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T298 | ECGA000298 | 0.48 |
| 6690 | PIK3AP1 levels | GCST90470233 | 0.48 |
| 6691 | Use of antiglaucoma preparations and miotics | FING00001409 | 0.47 |
| 6692 | TREML2 levels | GCST90470962 | 0.47 |
| 6693 | F11R/SORT1 ratio | GCST90314726 | 0.47 |
| 6694 | Left-hemisphere dorsal attention network to amygdala white-matter structural connectivity | GCST90302706 | 0.47 |
| 6695 | Colon polyps | GCST90475319 | 0.47 |
| 6696 | CD74/NPDC1 ratio | GCST90313895 | 0.47 |
| 6697 | Mean reticulocyte volume | Blood count | UKBB00000451 | 0.47 |
| 6698 | Alcohol use disorder, Swedish definition | FING00000053 | 0.47 |
| 6699 | DPP6 levels | GCST90469034 | 0.47 |
| 6700 | SUMF1 levels | GCST90470783 | 0.47 |
| 6701 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T278 | ECGU000278 | 0.47 |
| 6702 | Hair colour (natural, before greying) - Black | Sun exposure | UKBB00000295 | 0.47 |
| 6703 | TNF/TNFRSF1B ratio | GCST90315942 | 0.47 |
| 6704 | Primary coxarthrosis, bilateral | FING00001212 | 0.47 |
| 6705 | DKK1/VASH1 ratio | GCST90314482 | 0.47 |
| 6706 | Leg fat mass (left) | Impedance measures | UKBB00000389 | 0.47 |
| 6707 | Maximum workload during fitness test | ECG during exercise | UKBB00000432 | 0.47 |
| 6708 | Mean volume of bilateral amygdala | GCST90474992 | 0.47 |
| 6709 | Appendicular lean mass | GCST90000026 | 0.46 |
| 6710 | MGLL/PDLIM7 ratio | GCST90315438 | 0.46 |
| 6711 | KLK4 levels | GCST90469704 | 0.46 |
| 6712 | IDP dMRI TBSS ICVF Cingulum cingulate gyrus R | GCST90004361 | 0.46 |
| 6713 | Operation code - hip replacement/revision | Operations | UKBB00000558 | 0.46 |
| 6714 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T162 | ECGU000162 | 0.46 |
| 6715 | Diaphragmatic hernia | FING00000419 | 0.46 |
| 6716 | DSG3/SPINK5 ratio | GCST90314561 | 0.46 |
| 6717 | GOLM2/ITGA5 ratio | GCST90314951 | 0.46 |
| 6718 | ALDH1A1/CA2 ratio | GCST90313243 | 0.46 |
| 6719 | Body fat percentage (adjusted for testosterone and SHBG) | GCST90432180 | 0.46 |
| 6720 | BCR/NFATC1 ratio | GCST90313496 | 0.46 |
| 6721 | DTI TBSS L2 Posterior corona radiata L | GCST90384503 | 0.46 |
| 6722 | Fracture of hand or wrist (PheCode 804) | GCST90476281 | 0.46 |
| 6723 | PIK3IP1/RGMB ratio | GCST90315652 | 0.46 |
| 6724 | CTSL levels | GCST90012073 | 0.46 |
| 6725 | Insomnia (standard GWA) | GCST90267286 | 0.46 |
| 6726 | Type 2 diabetes | endocrine/metabolic | UKBB00000867 | 0.46 |
| 6727 | LTBR levels | GCST90469816 | 0.46 |
| 6728 | Bone marrow fat fraction of thoracic vertebra 11 | GCST90652383 | 0.46 |
| 6729 | Microalbumin urine | GCST90278639 | 0.46 |
| 6730 | Cholecystectomy | FING00000273 | 0.45 |
| 6731 | CASP7 levels | GCST90468547 | 0.45 |
| 6732 | TIMD4 levels | GCST90470866 | 0.45 |
| 6733 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502649 | 0.45 |
| 6734 | Sodium (mean, inv-norm transformed) | GCST90476395 | 0.45 |
| 6735 | Gout (PheCode 274.1) | GCST90475735 | 0.45 |
| 6736 | FGL1 levels | GCST90469235 | 0.45 |
| 6737 | DTI TBSS L3 Superior cerebellar peduncle R | GCST90384536 | 0.45 |
| 6738 | Serum 25-Hydroxyvitamin D levels | GCST90000614 | 0.45 |
| 6739 | EFEMP1 levels | GCST90469078 | 0.45 |
| 6740 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T297 | ECGU000297 | 0.45 |
| 6741 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T275 | ECGU000275 | 0.45 |
| 6742 | CD38/RELT ratio | GCST90313809 | 0.45 |
| 6743 | IDP dMRI TBSS L2 Anterior corona radiata L | GCST90004146 | 0.45 |
| 6744 | Heart failure with preserved EF [Diastolic heart failure] (PheCode 428.4) | GCST90475984 | 0.45 |
| 6745 | Left ventricular wall thickness (mean) | GCST90435264 | 0.45 |
| 6746 | ADH4/KYNU ratio | GCST90313193 | 0.45 |
| 6747 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T152 | ECGU000152 | 0.45 |
| 6748 | EBAG9 levels | GCST90469059 | 0.45 |
| 6749 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T277 | ECGA000277 | 0.45 |
| 6750 | TGFBR2/THBD ratio | GCST90315916 | 0.45 |
| 6751 | Principal component-derived dietary pattern 44 | GCST90133049 | 0.45 |
| 6752 | TAX1BP1 levels | GCST90470808 | 0.45 |
| 6753 | Alcohol drinker status - Current | Alcohol | UKBB00000021 | 0.45 |
| 6754 | Other disorders of urethra and urinary system | FING00001039 | 0.45 |
| 6755 | SGSH levels | GCST90470615 | 0.44 |
| 6756 | Prescriptions - sulfonylurea|diabetes | UKBB00000703 | 0.44 |
| 6757 | Spinal stenosis | musculoskeletal | UKBB00000792 | 0.44 |
| 6758 | Physical activity (Total log acceleration 10pm-12am) | GCST90061420 | 0.44 |
| 6759 | Other maternal disorders predominantly related to pregnancy | FING00001069 | 0.44 |
| 6760 | Erythematous conditions (PheCode 695) | GCST90476177 | 0.44 |
| 6761 | Heel bone mineral density (BMD) T-score, automated (right) | Bone-densitometry of heel | UKBB00000317 | 0.44 |
| 6762 | CD58/MEGF10 ratio | GCST90313853 | 0.44 |
| 6763 | SFRP4 levels | GCST90470611 | 0.44 |
| 6764 | Heel quantitative ultrasound index (QUI), direct entry (right) | Bone-densitometry of heel | UKBB00000323 | 0.44 |
| 6765 | AFM levels | GCST90468249 | 0.44 |
| 6766 | DCTN1/FXN ratio | GCST90314430 | 0.44 |
| 6767 | FAP/THBS4 ratio | GCST90314785 | 0.44 |
| 6768 | Liver enzyme levels (alanine transaminase) | GCST90013405 | 0.44 |
| 6769 | Severe autoimmune type 2 diabetes | GCST90026412 | 0.44 |
| 6770 | CCN3/COL6A3 ratio | GCST90313720 | 0.44 |
| 6771 | ITGA6/THPO ratio | GCST90315208 | 0.44 |
| 6772 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T322 | ECGA000322 | 0.44 |
| 6773 | Weight (UKB data field 21002) | GCST90468183 | 0.44 |
| 6774 | IDP dMRI ProbtrackX ISOVF ifo r | GCST90004538 | 0.44 |
| 6775 | Heel bone mineral density (BMD) (right) | Bone-densitometry of heel | UKBB00000314 | 0.44 |
| 6776 | Multiple sclerosis | GCST90475833 | 0.44 |
| 6777 | F10 levels | GCST90469163 | 0.44 |
| 6778 | Uterine fibroids | GCST90461958 | 0.44 |
| 6779 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T220 | ECGU000220 | 0.44 |
| 6780 | Aneurysms, operations, SAH | FING00000085 | 0.43 |
| 6781 | Allergic rhinitis | FING00000071 | 0.43 |
| 6782 | DAG1/F2R ratio | GCST90314374 | 0.43 |
| 6783 | Bone marrow fat fraction of lumbar vertebra 4 | GCST90652389 | 0.43 |
| 6784 | Body mass index | GCST004904 | 0.43 |
| 6785 | Coxarthrosis, primary | FING00000363 | 0.43 |
| 6786 | IDP dMRI ProbtrackX MD cgh l | GCST90004225 | 0.43 |
| 6787 | IDP dMRI ProbtrackX MD ifo r | GCST90004232 | 0.43 |
| 6788 | UFC1 levels | GCST90243245 | 0.43 |
| 6789 | Qualifications - Other professional qualifications eg: nursing, teaching | Education | UKBB00000732 | 0.43 |
| 6790 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T312 | ECGU000312 | 0.43 |
| 6791 | aparc-DKTatlas rh area postcentral | GCST90003285 | 0.43 |
| 6792 | Left-hemisphere default mode network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302763 | 0.43 |
| 6793 | Nonspecific chest pain (PheCode 418) | GCST90475947 | 0.43 |
| 6794 | Types of transport used (excluding work) - Walk | Physical activity | UKBB00000879 | 0.43 |
| 6795 | Sleeplessness / insomnia | Sleep | UKBB00000778 | 0.43 |
| 6796 | aseg global volume Brain-Stem | GCST90002602 | 0.43 |
| 6797 | X-21467 levels | GCST90200594 | 0.43 |
| 6798 | Heel broadband ultrasound attenuation (right) | Bone-densitometry of heel | UKBB00000320 | 0.43 |
| 6799 | BLVRB/HAGH ratio | GCST90313524 | 0.43 |
| 6800 | IDP dMRI ProbtrackX L3 ifo l | GCST90004312 | 0.43 |
| 6801 | Gout and other crystal arthrop (PheCode 274) | GCST90475731 | 0.43 |
| 6802 | Feeling lonely | GCST006942 | 0.43 |
| 6803 | CTSH levels | GCST90468913 | 0.43 |
| 6804 | Whiskey liking | GCST90094873 | 0.43 |
| 6805 | Skin luminance | GCST90320257 | 0.43 |
| 6806 | aparc-a2009s lh area S-orbital-med-olfact | GCST90003359 | 0.43 |
| 6807 | RHOC/TBCB ratio | GCST90315774 | 0.43 |
| 6808 | CDH17/GALNT3 ratio | GCST90313940 | 0.43 |
| 6809 | LAYN/TNFRSF4 ratio | GCST90315291 | 0.43 |
| 6810 | F-cheese liking (derived food-liking factor) | GCST90094729 | 0.43 |
| 6811 | Non-insulin-dependent diabetes mellitus | Diabetes mellitus | UKBB00000524 | 0.43 |
| 6812 | IDP dMRI ProbtrackX ISOVF ar r | GCST90004526 | 0.42 |
| 6813 | Free cholesterol levels in IDL | GCST90132676 | 0.42 |
| 6814 | Principal component-derived dietary pattern 43 | GCST90133048 | 0.42 |
| 6815 | CD59/CST6 ratio | GCST90313857 | 0.42 |
| 6816 | Retinal nerve fibre layer (RNFL) thickness | GCST90014266 | 0.42 |
| 6817 | Alcohol frequency weekly (weighted GWA) | GCST90267267 | 0.42 |
| 6818 | CD40LG/EGF ratio | GCST90313819 | 0.42 |
| 6819 | Mean spheric corpuscular volume | GCST90002397 | 0.42 |
| 6820 | aseg rh intensity Accumbens-area | GCST90003788 | 0.42 |
| 6821 | Platelet distribution width (UKB data field 30110) | GCST90468097 | 0.42 |
| 6822 | Prescriptions - bisoprolol | selective beta1 antagonist,beta blocker | UKBB00000672 | 0.42 |
| 6823 | Principal component-derived dietary pattern 32 | GCST90133037 | 0.42 |
| 6824 | Systolic blood pressure | GCST90278642 | 0.42 |
| 6825 | BTN2A1/IFNGR1 ratio | GCST90313543 | 0.42 |
| 6826 | DTI autoptx FA atr l tract | GCST90385114 | 0.42 |
| 6827 | Cerotoylcarnitine (C26) levels | GCST90200136 | 0.42 |
| 6828 | ANXA3/ENO2 ratio | GCST90313281 | 0.42 |
| 6829 | SLC51B levels | GCST90470664 | 0.42 |
| 6830 | Uric acid levels | GCST90278646 | 0.42 |
| 6831 | Plasma betaine levels in chronic kidney disease | GCST90264858 | 0.42 |
| 6832 | CLEC1B/SORT1 ratio | GCST90314104 | 0.42 |
| 6833 | MAP3K5 levels | GCST90469854 | 0.41 |
| 6834 | SESTD1 levels | GCST90470604 | 0.41 |
| 6835 | Spherical power (right) | Autorefraction | UKBB00000791 | 0.41 |
| 6836 | PSAP levels | GCST90470351 | 0.41 |
| 6837 | DEFB4A or DEFB4B levels | GCST90468984 | 0.41 |
| 6838 | Glucose (fasting status unknown, maximum, inv-norm transformed) | GCST90475329 | 0.41 |
| 6839 | RNASET2 levels | GCST90470481 | 0.41 |
| 6840 | Illnesses of father - None of the above (group 1) | Family history | UKBB00000345 | 0.41 |
| 6841 | Gamma glutamyltransferase | Blood biochemistry | UKBB00000275 | 0.41 |
| 6842 | CDC37/SNX9 ratio | GCST90313936 | 0.41 |
| 6843 | Nonalcoholic steatohepatitis | FING00000879 | 0.41 |
| 6844 | CA2/HMBS ratio | GCST90313579 | 0.41 |
| 6845 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T136 | ECGU000136 | 0.41 |
| 6846 | aparc-a2009s rh volume S-front-inf | GCST90003050 | 0.41 |
| 6847 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T223 | ECGU000223 | 0.41 |
| 6848 | Otitis media (PheCode 381.1) | GCST90475903 | 0.41 |
| 6849 | TNFRSF10A levels | GCST90470899 | 0.41 |
| 6850 | Cognitive processing speed | GCST90446168 | 0.41 |
| 6851 | IDP dMRI ProbtrackX ICVF cgc r | GCST90004380 | 0.41 |
| 6852 | USP8/WASF1 ratio | GCST90315944 | 0.41 |
| 6853 | Platelet count during third trimester of pregnancy | GCST90302226 | 0.40 |
| 6854 | TFPI levels | GCST90470839 | 0.40 |
| 6855 | Total cholesterol levels in small LDL | GCST90132690 | 0.40 |
| 6856 | IDP dMRI TBSS L3 Superior fronto-occipital fasciculus R | GCST90004213 | 0.40 |
| 6857 | IDP SWI T2star left pallidum | GCST90003869 | 0.40 |
| 6858 | Right-hemisphere visual network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302777 | 0.40 |
| 6859 | ENG/TNFRSF10C ratio | GCST90314650 | 0.40 |
| 6860 | Aspartate aminotransferase (AST, maximum, inv-norm transformed) | GCST90475118 | 0.40 |
| 6861 | Qualifications - CSEs or equivalent | Education | UKBB00000728 | 0.40 |
| 6862 | BSG/LAMP3 ratio | GCST90313533 | 0.40 |
| 6863 | CTRB1 levels | GCST90468905 | 0.40 |
| 6864 | Unstable angina pectoris | GCST90018712 | 0.40 |
| 6865 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T306 | ECGA000306 | 0.40 |
| 6866 | Treatment speciality of consultant (recoded) - Cardiology | Summary Administration | UKBB00000829 | 0.40 |
| 6867 | Cardiomyopathy (excluding other) | FING00000251 | 0.40 |
| 6868 | TSPAN8 levels | GCST90470980 | 0.40 |
| 6869 | Degree of unsaturation | GCST90502230 | 0.40 |
| 6870 | Cryptic phenotype that captures Alport syndrome severity | GCST90101828 | 0.40 |
| 6871 | MAVS/MZT1 ratio | GCST90315391 | 0.40 |
| 6872 | Fracture of lower leg, including ankle | FING00000555 | 0.40 |
| 6873 | CPXM1/LGMN ratio | GCST90314220 | 0.40 |
| 6874 | DTNB levels | GCST90469046 | 0.40 |
| 6875 | T1 FreeSurfer aseg Left-Caudate | GCST90384144 | 0.40 |
| 6876 | TNFRSF13B levels | GCST90470905 | 0.40 |
| 6877 | Vascular/heart problems diagnosed by doctor - Heart attack | Medical conditions | UKBB00000897 | 0.40 |
| 6878 | REG1A levels | GCST90470447 | 0.40 |
| 6879 | Insulin pump user (PheCode 250.3) | GCST90475680 | 0.39 |
| 6880 | IDP dMRI TBSS L3 Sagittal stratum R | GCST90004201 | 0.39 |
| 6881 | Comparative height size at age 10 | Early life factors | UKBB00000143 | 0.39 |
| 6882 | DTI TBSS L3 Anterior limb of internal capsule L | GCST90384541 | 0.39 |
| 6883 | EHD3 levels | GCST90469089 | 0.39 |
| 6884 | Bone marrow fat fraction of thoracic vertebra 10 | GCST90652382 | 0.39 |
| 6885 | Principal component-derived dietary pattern 52 | GCST90133056 | 0.39 |
| 6886 | IDP dMRI TBSS L2 Retrolenticular part of internal capsule R | GCST90004143 | 0.39 |
| 6887 | GP6/SEMA4D ratio | GCST90314971 | 0.39 |
| 6888 | IDP dMRI TBSS L1 Posterior limb of internal capsule R | GCST90004093 | 0.39 |
| 6889 | AXIN1 levels | GCST90468405 | 0.39 |
| 6890 | ITGB1BP2 levels | GCST90469642 | 0.39 |
| 6891 | SDC4/SEMA4D ratio | GCST90315818 | 0.39 |
| 6892 | GLRX2 levels | GCST90241278 | 0.39 |
| 6893 | Other follicular disorders | FING00001050 | 0.39 |
| 6894 | EGF/MANF ratio | GCST90314609 | 0.39 |
| 6895 | Plasma homoarginine levels in chronic kidney disease | GCST90265345 | 0.39 |
| 6896 | GLB1/GUSB ratio | GCST90314931 | 0.39 |
| 6897 | TMPRSS11D levels | GCST90470891 | 0.39 |
| 6898 | TXNDC5 levels | GCST90470991 | 0.39 |
| 6899 | Urate levels (UKB data field 30880) | GCST90468107 | 0.39 |
| 6900 | Number of vehicles in household | Household | UKBB00000543 | 0.39 |
| 6901 | EFEMP1/FSTL3 ratio | GCST90314595 | 0.38 |
| 6902 | FVC | GCST90278629 | 0.38 |
| 6903 | CC2D1A/WWP2 ratio | GCST90313668 | 0.38 |
| 6904 | FCRL1/TREML2 ratio | GCST90314797 | 0.38 |
| 6905 | Treatment/medication code - metformin | Medications | UKBB00000851 | 0.38 |
| 6906 | rfMRI connectivity ICA-features 1 | GCST90006339 | 0.38 |
| 6907 | Anal and rectal conditions | digestive | UKBB00000029 | 0.38 |
| 6908 | NT5E levels | GCST90470093 | 0.38 |
| 6909 | HSPG2 levels | GCST90179392 | 0.38 |
| 6910 | Alkenylphosphatidylcholine (P-16:0/16:0) levels | GCST90025563 | 0.38 |
| 6911 | IDP dMRI TBSS MD Superior corona radiata R | GCST90004051 | 0.38 |
| 6912 | Types of transport used (excluding work) - Cycle | Physical activity | UKBB00000877 | 0.38 |
| 6913 | DARS1 levels | GCST90468947 | 0.38 |
| 6914 | Multiple myeloma and malignant plasma cell neoplasms (controls excluding all cancers) | FING00000843 | 0.38 |
| 6915 | Depressive symptomatology (confirmatory factor analysis Factor 2) | GCST90309337 | 0.38 |
| 6916 | SCRN1 levels | GCST90470556 | 0.38 |
| 6917 | Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers) | FING00000768 | 0.38 |
| 6918 | Fracture of rib(s), sternum and thoracic spine | FING00000558 | 0.38 |
| 6919 | CRTAM/ICAM3 ratio | GCST90314276 | 0.38 |
| 6920 | CD300C levels | GCST90468620 | 0.38 |
| 6921 | Exotropia | GCST90572737 | 0.38 |
| 6922 | IDP dMRI TBSS MD Posterior corona radiata L | GCST90004054 | 0.37 |
| 6923 | PRSS8 levels | GCST90470345 | 0.37 |
| 6924 | CPXM1/SPARC ratio | GCST90314222 | 0.37 |
| 6925 | CD46/THBD ratio | GCST90313836 | 0.37 |
| 6926 | PGF levels | GCST90470218 | 0.37 |
| 6927 | GPI levels | GCST90469391 | 0.37 |
| 6928 | Gastric polyp | GCST90018630 | 0.37 |
| 6929 | CLEC1A levels | GCST90468767 | 0.37 |
| 6930 | Otitis media and Eustachian tube disorders (PheCode 381) | GCST90475902 | 0.37 |
| 6931 | DTI TBSS L1 External capsule R | GCST90384460 | 0.37 |
| 6932 | ARSA/GUSB ratio | GCST90313355 | 0.37 |
| 6933 | HippSubfield lh volume Hippocampal-tail | GCST90002668 | 0.37 |
| 6934 | CA11 levels | GCST90468506 | 0.37 |
| 6935 | Alcohol use and misuse (confirmatory factor analysis Factor 22) | GCST90309356 | 0.37 |
| 6936 | IDP T1 FAST ROIs L cerebellum I-IV | GCST90002562 | 0.37 |
| 6937 | PLCB2 levels | GCST90470255 | 0.37 |
| 6938 | CD79B/TNFRSF13B ratio | GCST90313902 | 0.37 |
| 6939 | FABP4 levels | GCST90012075 | 0.37 |
| 6940 | Pain type(s) experienced in last month - Neck or shoulder pain | Pain | UKBB00000630 | 0.37 |
| 6941 | rfMRI connectivity (ICA25 edge 101) | GCST90004744 | 0.37 |
| 6942 | Principal component-derived dietary pattern 8 | GCST90133013 | 0.36 |
| 6943 | TIMM8A levels | GCST90470868 | 0.36 |
| 6944 | ESAM/FUT8 ratio | GCST90314711 | 0.36 |
| 6945 | CLEC5A levels | GCST90468776 | 0.36 |
| 6946 | IDP T1 FAST ROIs R cerebellum VI | GCST90002568 | 0.36 |
| 6947 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T296 | ECGU000296 | 0.36 |
| 6948 | MAVS/PPP1R9B ratio | GCST90315393 | 0.36 |
| 6949 | DTI autoptx L2 unc l tract | GCST90385191 | 0.36 |
| 6950 | REG1A/TFF3 ratio | GCST90315764 | 0.36 |
| 6951 | Phosphatidylcholine (40:8) levels | GCST90025538 | 0.36 |
| 6952 | Fasciitis | musculoskeletal | UKBB00000239 | 0.36 |
| 6953 | AZU1/MPO ratio | GCST90313425 | 0.36 |
| 6954 | DOK2/LACTB2 ratio | GCST90314532 | 0.36 |
| 6955 | KLK8 levels | GCST90425492 | 0.36 |
| 6956 | CNST levels | GCST90468801 | 0.36 |
| 6957 | Heart attack | GCST90468132 | 0.36 |
| 6958 | MAPK13 levels | GCST90241949 | 0.36 |
| 6959 | IDP dMRI TBSS MD Superior longitudinal fasciculus L | GCST90004068 | 0.36 |
| 6960 | Malignant neoplasm of bronchus and lung | Malignant neoplasms of respiratory and intrathoracic organs | UKBB00000425 | 0.36 |
| 6961 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T139 | ECGU000139 | 0.36 |
| 6962 | Calculus of lower urinary tract | FING00000237 | 0.36 |
| 6963 | Disorders of vitreous body | FING00000465 | 0.36 |
| 6964 | TLR4 levels | GCST90470880 | 0.36 |
| 6965 | F2R/SNX9 ratio | GCST90314736 | 0.36 |
| 6966 | ODAM levels | GCST90470115 | 0.36 |
| 6967 | Sciatica+with lumbago | FING00001279 | 0.36 |
| 6968 | B4GAT1 levels | GCST90468413 | 0.36 |
| 6969 | Cereal type: Biscuit cereal (e.g. Weetabix) (UKB data field 1468_2) | GCST90132969 | 0.36 |
| 6970 | Heel bone mineral density | GCST006288 | 0.35 |
| 6971 | WASL levels | GCST90471070 | 0.35 |
| 6972 | Illnesses of mother - Diabetes | Family history | UKBB00000347 | 0.35 |
| 6973 | CD69/PPP1R2 ratio | GCST90313882 | 0.35 |
| 6974 | PINLYP levels | GCST90470238 | 0.35 |
| 6975 | Severity of induration at injection site at the injection site after COVID-19 booster vaccination | GCST90454409 | 0.35 |
| 6976 | Witnessed sudden violent death | Traumatic events | UKBB00000917 | 0.35 |
| 6977 | ACE2 levels | GCST90468197 | 0.35 |
| 6978 | Two-hour glucose | GCST90002227 | 0.35 |
| 6979 | Gout, unspecified | FING00000589 | 0.35 |
| 6980 | Other specified/unspecified inflammatory spondylopathies | FING00001109 | 0.35 |
| 6981 | C-reactive protein levels (UKB data field 30710) | GCST90468064 | 0.35 |
| 6982 | MIA levels | GCST90469903 | 0.35 |
| 6983 | ALCAM/ICAM3 ratio | GCST90313237 | 0.35 |
| 6984 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T118 | ECGU000118 | 0.35 |
| 6985 | Other arthritis (FG) | FING00000964 | 0.35 |
| 6986 | Total testosterone levels | GCST90503313 | 0.35 |
| 6987 | DTI TBSS L3 Superior longitudinal fasciculus R | GCST90384564 | 0.35 |
| 6988 | MAP2K6/TBL1X ratio | GCST90315378 | 0.35 |
| 6989 | aparc-Desikan rh area postcentral | GCST90003128 | 0.35 |
| 6990 | Mean reticulocyte volume (UKB data field 30260) | GCST90468088 | 0.35 |
| 6991 | ENTPD2 levels | GCST90469120 | 0.34 |
| 6992 | XRCC4 levels | GCST90471085 | 0.34 |
| 6993 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 68) | GCST90320631 | 0.34 |
| 6994 | Diacylglycerol_34:3_[M+H-H2O]1+ levels | GCST90060177 | 0.34 |
| 6995 | AGXT/MME ratio | GCST90313207 | 0.34 |
| 6996 | YTHDF3 levels | GCST90471091 | 0.34 |
| 6997 | Mean arterial pressure, manual reading | Cardiovascular measurement | UKBB00000441 | 0.34 |
| 6998 | Leiomyoma of uterus | FING00000719 | 0.34 |
| 6999 | MMP3 levels | GCST90469920 | 0.34 |
| 7000 | Leg fat percentage right (UKB data field 23111) | GCST90468175 | 0.34 |